Executive Summary
A surge in SPAC IPO filings dominates the March 6, 2026, IPO pipeline with three blank check companies (Apogee, Patriot, ACP Holdings) registering standard $10 units and $11.50 warrants, signaling a potential SPAC market revival targeting tech sectors and generating up to $480M in combined proceeds. Northfield Bancorp's S-1 reveals a shrinking loan book at -4.1% YoY to $3.86B, driven by -9.1% multifamily decline (61% of portfolio), though offset by +24.0% construction and +14.1% home equity growth, amid mixed deposit market shares (9.64% in Staten Island vs 0.65% Brooklyn). An S-4 filing tied to Northfield Bancorp (CIK 0002115119) hints at merger activity with financial tags spanning 2022-2025 across loans and securities, lacking quantitative trends but covering credit quality segments. No forward-looking guidance or insider sales noted across filings, but sponsor founder shares (e.g., Apogee's 9.3M, Patriot's 5.75M) indicate strong alignment. Portfolio-level trends show SPACs as bullish outliers with positive sentiment vs Northfield's mixed, highlighting bifurcation between speculative vehicles and operating banks facing YoY contraction. Implications include near-term liquidity influx for de-SPAC hunts and caution on banking IPOs amid competition and loan softness.
Tracking the trend? Catch up on the prior US IPO Pipeline SEC S-1 Filings digest from March 05, 2026.
Investment Signals(12)
- Apogee Acquisition Corp(BULLISH)▲
IPO of 25M units at $10 targeting $250M proceeds in tech/software/hardware; sponsor holds 9.3M founder shares (25% post-IPO ownership) for $25K cost, signaling high management skin-in-game
- Patriot Acquisition Corp(BULLISH)▲
20M firm units at $10 for $200M + 3M over-allotment option (+$30M); sponsor's 5.75M founder shares at $25K cost ensure 20%+ alignment, deferred commissions structured for BC success
- ACP Holdings Acquisition Corp(BULLISH)▲
Standard SPAC warrant terms ($11.50 exercise post-BC, 5-year expiry) identical to public except transfer restrictions, providing familiarity and liquidity post-separation
- Northfield Bancorp(BULLISH)▲
Construction loans +24.0% YoY to $45M and home equity +14.1% to $199M outperform total portfolio -4.1% decline, with all $168.9M participations performing
- Apogee vs Patriot(BULLISH)▲
Both SPACs feature identical $11.50 warrants (half per unit, exercisable 12/30 days post-BC), but Apogee's larger 25M units vs Patriot's 20M indicate scaled ambition
- Patriot Acquisition Corp(BULLISH)▲
Founder shares represent ~22% post-IPO (vs Apogee 25%), with over-allotment forfeiture protection up to 3M units mirroring SPAC best practices
- Northfield Bancorp(BULLISH)▲
Median household incomes in markets +12-16% YoY above national avg, supporting loan demand despite unemployment 3.6-5.5% (mixed YoY)
- Northfield Merger Entity (S-4)(BULLISH)▲
Comprehensive tags for Northfield loans/securities 2022-2025 (e.g., CRE, multifamily, substandard) signal detailed due diligence in potential BC
- SPAC Trio(BULLISH)▲
Uniform $10 unit pricing and trust deposits across Apogee/Patriot/ACP ensure redemption protection at ~$10/share, vs Northfield's operational risks
- Northfield Bancorp(BULLISH)▲
Weighted avg rates strong (C&I 7.24%, CRE 5.25%) position for NIM stability amid portfolio shifts
- Apogee Acquisition Corp(BULLISH)▲
Private placement 470K units for $4.7M concurrent with IPO locks sponsor commitment
- Patriot vs ACP(BULLISH)▲
Deferred commissions 4-5.5% (up to $9.65M) incentivize underwriter success, standard vs peers
Risk Flags(9)
- Northfield Bancorp/Loan Portfolio[HIGH RISK]▼
Total loans -4.1% YoY to $3.86B from $4.02B, driven by multifamily -9.1% to $2.36B (61% of portfolio)
- Northfield Bancorp/Deposits[MEDIUM RISK]▼
Low market share 0.65% Brooklyn, 1.75% NJ counties vs 9.64% Staten Island amid intense competition
- Northfield Bancorp/Unemployment[MEDIUM RISK]▼
Rates 3.6-5.5% (above national 4.4%), flat YoY in Kings County NY at 5.5% signals soft demand
- Apogee Acquisition Corp/Forfeiture[LOW RISK]▼
Up to 1.25M founder shares (13% of 9.3M) forfeitable on underwriter over-allotments, diluting sponsor if undersubscribed
- Patriot Acquisition Corp/Commissions[MEDIUM RISK]▼
$8M deferred (4%) on firm + up to $1.65M (5.5%) on options payable only on BC or forfeited on liquidation
- Northfield Merger Entity (S-4)/Data Gaps[HIGH RISK]▼
No numerical YoY/QoQ for 2022-2025 loan/credit tags (pass/substandard/delinquent), obscuring trends
- Northfield Bancorp/Concentration[HIGH RISK]▼
Multifamily 61% of loans vulnerable post -9.1% YoY drop
- SPAC Trio/No Targets[MEDIUM RISK]▼
All pre-deal with limited activities, historical SPAC redemption risks at BC (~$10/share)
- ACP Holdings Acquisition Corp/Warrants[LOW RISK]▼
Transfer restrictions on private/working capital warrants until 30 days post-BC limit flexibility
Opportunities(10)
- Apogee Acquisition Corp/IPO Sizing(OPPORTUNITY)◆
Largest at 25M units/$250M positions for high-profile tech targets, sponsor alignment via 25% founder shares
- Patriot Acquisition Corp/Over-Allotment(OPPORTUNITY)◆
3M unit option (+15%) exercisable 45 days post-effective, potential $30M upside for scaled trust
- Northfield Bancorp/Loan Growth Segments(OPPORTUNITY)◆
+24% construction/$45M, +14.1% home equity/$199M as turnaround vs total -4.1%, enter pre-IPO
- Northfield Merger Entity (S-4)/BC Proxy(OPPORTUNITY)◆
Early S-4 with Northfield 2025 data (loans to Dec 31) flags de-SPAC timing ahead of peers
- ACP Holdings Acquisition Corp/Warrant Structure(OPPORTUNITY)◆
Identical public/private terms post-restrictions offer cheap upside at $11.50 exercise
- SPAC Trio/Unit Separation(OPPORTUNITY)◆
Trade separately 90 days post-IPO (Patriot) or post-8K, arbitrage warrants vs shares
- Northfield Bancorp/Market Rates(OPPORTUNITY)◆
High yields (6.06% home equity, 7.24% C&I) vs peers support relisting/IPO valuation
- Apogee vs Northfield(OPPORTUNITY)◆
SPAC dry powder $250M+ targets banks like Northfield with $3.86B loans, merger arb play
- Patriot Acquisition Corp/Sponsor Economics(OPPORTUNITY)◆
5.75M shares/$25K cost (Patriot) vs Apogee 9.3M similar, buy sponsor-linked PIPEs
- Northfield Bancorp/Performing Assets(OPPORTUNITY)◆
100% loan participations ($168.9M) performing, low NPL risk for IPO discount capture
Sector Themes(6)
- SPAC Revival Wave(BULLISH PIPELINE)◆
3/5 filings (Apogee/Patriot/ACP) same-day S-1s with $10 units/$250-200M proceeds, uniform $11.50 warrants signal dry powder for tech BCs post-downturn
- Banking Loan Contraction(BEARISH OUTLIER)◆
Northfield total loans -4.1% YoY, multifamily -9.1% (61% portfolio) vs growth in construction +24%, S-4 tags highlight CRE/multifamily risks 2022-2025
- Sponsor Alignment Standard(BULLISH MANAGEMENT)◆
Founder shares 20-25% post-IPO (Apogee 9.3M, Patriot 5.75M at $25K cost each), private placements lock commitment across SPACs
- Warrant Uniformity(NEUTRAL EFFICIENCY)◆
All SPACs $11.50 exercise 30-12 months post-BC, 5-year expiry, half/redeemable per unit reduces dilution vs historical terms
- Regional Bank Pressures(MIXED GEOGRAPHY)◆
Northfield deposits vary 0.65-9.64% share, unemployment > national avg, income growth +12-16% but competition intense
- Merger Proxy Emergence(EMERGING CATALYST)◆
S-4 with Northfield tags (loans/credit 2022-2025) amid 3 SPACs suggests de-SPAC targeting financials
Watch List(8)
- Apogee Acquisition Corp/Over-Allotments👁
Monitor up to 3.75M units and 1.25M founder share forfeitures post-underwriter exercise [Ongoing post-S-1 effective]
- Patriot Acquisition Corp/Unit Separation👁
Track 90-day post-IPO or 8-K for audited balance sheet to enable warrant/share trading [90 days from IPO]
- Patriot Acquisition Corp/Over-Allotment👁
3M unit option exercisable within 45 days of S-1 effective date [~April 2026]
- Northfield Bancorp/Loan Trends👁
Watch multifamily (61%, -9.1% YoY) and construction (+24%) updates in prospectus amendments [Pre-IPO pricing]
- Northfield Merger Entity (S-4)/BC Progress👁
Key dates 2024-12-13, 2025 periods; monitor for merger target reveal or proxy vote [Q2 2026 expected]
- ACP Holdings Acquisition Corp/Warrant Transfers👁
Private/working capital restrictions lift 30 days post-BC, watch for Permitted Transferee activity [Post-BC 2027+]
- SPAC Trio/Business Combination👁
No targets identified; track Form 8-Ks for LOIs within 24 months standard deadline [Through 2028]
- Northfield Bancorp/Deposit Competition👁
Staten Island 9.64% vs Brooklyn 0.65%; monitor market share in earnings/prospectus updates [Ongoing]
Filing Analyses(5)
06-03-2026
Apogee Acquisition Corp, a Cayman Islands-based blank check company (SPAC), filed an S-1 registration statement on March 6, 2026, for an initial public offering of 25,000,000 units at $10.00 each, targeting gross proceeds of $250,000,000, with a focus on acquiring technology-driven businesses in software, hardware, and related sectors. The Sponsor, Apogee Acquisition Sponsor LLC, will purchase 470,000 private placement units for $4,700,000 concurrently, and holds 9,303,333 founder shares (originally 9,583,333 purchased for $25,000 on November 20, 2025), with up to 1,250,000 subject to forfeiture based on underwriter over-allotments of up to 3,750,000 units. No target has been identified, and efforts remain limited to organizational activities.
- ·Each unit consists of one Class A ordinary share and one-half redeemable warrant (exercisable at $11.50 per share after 12 months post-IPO or business combination).
- ·Founder shares designed to represent 25% of outstanding ordinary shares post-offering (excluding private placement).
- ·Public shareholders can redeem shares at ~$10.00 per share upon business combination; no minimum net tangible assets requirement.
- ·Sponsor and affiliates transferred aggregate 280,000 founder shares to independent directors (50,000 each) and COO (80,000).
06-03-2026
Patriot Acquisition Corp./CI, a blank check company, filed an S-1 registration statement on March 6, 2026, for an IPO of 20 million Firm Units priced at $10 each, generating $200M in gross proceeds to be deposited into a trust account, with a 3 million unit over-allotment option potentially adding $30M. The Sponsor, Patriot Acquisition Sponsor LLC, holds 5.75 million Founder Shares issued on October 27, 2025, for $25,000, and deferred underwriting commissions total $8M (4%) for Firm Units and up to $1.65M (5.5%) for Option Units. Public Warrants included in Units are exercisable at $11.50 per share starting 30 days after a Business Combination, expiring five years thereafter.
- ·Over-allotment Option exercisable within 45 days of S-1 Effective Date.
- ·Deferred commissions payable upon Business Combination Closing or forfeited upon liquidation.
- ·Units trade separately 90 days post-IPO or upon Form 8-K filing with audited balance sheet.
06-03-2026
Unknown Company (CIK 0002115119) filed an S-4 registration statement on March 6, 2026, related to a business combination preliminarily classified as such. The filing references financial data for Northfield Bancorp, Inc. as of December 31, 2024, including tags for securities portfolios (e.g., municipal bonds, corporate debt, mortgage-backed securities), loan segments (e.g., commercial real estate, multifamily, construction, single-family, consumer), credit quality (pass, special mention, substandard), and delinquency statuses across multiple periods from 2022 to 2025. No numerical amounts, percentages, or period-over-period changes are specified in the provided content.
- ·Financial tags cover periods including 2023-01-01 to 2023-12-31, 2024-01-01 to 2024-12-31, and 2025-01-01 to 2025-12-31.
- ·Key dates referenced: 2022-12-14, 2023-05-25, 2019-06-06, 2023-05-01, 2024-12-13, 2024-03-06.
06-03-2026
Northfield Bancorp filed an S-1 registration statement on March 6, 2026, for an IPO, providing details on its subsidiary Northfield Bank, a federally chartered savings bank founded in 1887 with $3.86B in total loans as of December 31, 2025, reflecting a 4.1% YoY decline from $4.02B primarily due to a 9.1% drop in multifamily loans (61% of portfolio, $2.36B). However, segments like home equity loans grew 14.1% to $199M, construction loans increased 24.0% to $45M, and median household incomes in key markets rose 12-16% YoY to levels above the national average. Deposit market share stood at 9.64% in Staten Island (6th rank) but was lower at 0.65% in Brooklyn and 1.75% in select NJ counties amid intense competition.
- ·All loan participations ($168.9M total at Dec 31, 2025) were performing in accordance with terms.
- ·Unemployment rates in served areas ranged 3.6%-5.5% at Dec 31, 2025, generally above national average of 4.4% with mixed YoY changes (e.g., Kings County, NY flat at 5.5%).
- ·Weighted average rates at Dec 31, 2025: multifamily 4.25%, commercial real estate 5.25%, home equity 6.06%, commercial & industrial 7.24%.
- ·Loan portfolio maturities: 3% due in one year or less ($109M), with bulk in longer terms.
06-03-2026
ACP Holdings Acquisition Corp. filed an S-1 registration statement on March 6, 2026, for its IPO as a SPAC, detailing terms of its Warrants which are exercisable at $11.50 per Class A Share starting 30 days after completion of an initial Business Combination and expiring 5 years thereafter. Private Placement Warrants and Working Capital Warrants have transfer restrictions until 30 days post-Business Combination, with limited exceptions for Permitted Transferees. No financial performance metrics or period-over-period comparisons are provided in the excerpt.
- ·Warrants exercisable only after effective registration statement or exemption; Company not obligated to net cash settle.
- ·Private Placement Warrants identical to Public Warrants except for 30-day post-Business Combination transfer restrictions.
- ·Houston, TX business address: 3131 Eastside, ZIP 77098; Phone: 832.810.6648.
- ·Fiscal year end: December 31; State of incorporation: E9 (likely Cayman Islands based on context).
Get daily alerts with 12 investment signals, 9 risk alerts, 10 opportunities and full AI analysis of all 5 filings
🇺🇸 More from United States
View all →March 26, 2026
US Pre-Market SEC Filings Roundup — March 26, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
Biotech Small-Cap Approvals — March 25, 2026
Biotech Small-Cap Approvals
March 25, 2026
New Drug Approvals (Original) — March 25, 2026
New Drug Approvals (Original)